|
시장보고서
상품코드
2038978
디지털 바이오마커 시장 : 유형별, 데이터 유형별, 기술 플랫폼별, 최종사용자별, 지역별Digital Biomarker Market, By Type, By Data Type, By Technology Platform, By End User, By Geography |
||||||
세계의 디지털 바이오마커 시장은 2026년에 48억 5,000만 달러로 추정되고 있으며, 2033년에 169억 달러에 달할 것으로 예상되고 있습니다. 2026-2033년 연평균 성장률(CAGR)은 19.5%에 달할 전망입니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 48억 5,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 19.50% | 2033년 시장 규모 예측 : | 169억 달러 |
디지털 바이오마커는 웨어러블 기기, 스마트폰, 기타 센서 등 다양한 디지털 기술을 통해 생물학적 데이터를 정량적으로 분석할 수 있는 기회를 제공하므로 현대 헬스케어의 획기적인 발전으로 여겨지고 있습니다. 잦은 내원 및 검사가 필요한 기존 바이오마커와 달리 디지털 바이오마커는 지속적이고 수동적으로 정보를 수집할 수 있으며, 환자의 건강 상태, 다양한 질환의 진행 상황, 치료 결과를 보다 정확하게 평가할 수 있습니다. 디지털 바이오마커의 진화는 현재의 헬스케어가 데이터베이스, 성과 중심의 모델로 변화하는 데 일조하고 있습니다.
세계의 디지털 바이오마커 산업은 심혈관질환, 신경질환, 호흡기질환, 정신질환 등의 치료 영역에서 다양한 응용분야를 포함하고 있습니다. 디지털 바이오마커는 생리적 정보, 행동 데이터, 환경 지표, 기타 정보 등 다양한 데이터 소스로부터 생성할 수 있습니다. 센서, 클라우드 컴퓨팅, 데이터 집약의 기술 발전은 디지털 바이오마커의 성장과 보급에 기여하고 있습니다.
시장 역학
세계의 디지털 바이오마커 시장은 헬스케어 업무의 디지털화, 가치 중심의 헬스케어 제공 및 연구로 인해 성장하고 있습니다. 보다 구체적으로, 헬스케어 부문의 이해관계자들은 의사결정 능력과 환자 치료 결과를 개선하기 위해 환자에 대한 객관적이고 빈번한 데이터를 수집할 수 있는 방법을 모색하고 있습니다. 디지털 바이오마커를 활용하면 환자는 데이터를 수집하고 이를 정량화할 수 있는 디지털 엔드포인트로서 임상 현장이나 제약 연구에 적용할 수 있습니다. 또한 클라우드 컴퓨팅 시스템, 모바일 헬스 기술, 데이터 상호운용성 향상으로 앞서 언급한 솔루션의 확장성과 적용성이 향상되고 있습니다.
그러나 헬스케어 분야에서 디지털 바이오마커를 활용하는 데에는 여러 기기에서 생성되는 데이터의 편차를 제어할 수 없다는 점, 충분히 검증되지 않은 솔루션, 데이터 거버넌스 관련 문제 등의 한계가 있습니다. 그럼에도 불구하고 디지털 트윈 기술의 적용, 멀티모달 데이터 분석, 헬스케어, 제약, 기술 등 다양한 분야의 관계자들 간의 협력에는 많은 기회가 숨겨져 있습니다. 디지털 바이오마커의 적용 범위가 조사에서 인구 헬스케어, 위험 식별, 치료로 확대되는 것은 디지털 바이오마커 시장의 성장에 더욱 기여할 수 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 글로벌 디지털 바이오마커 시장의 주요 기업 개요을 회사 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등 다양한 매개 변수를 기반으로 작성되었습니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 세계의 디지털 바이오마커 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 디지털 바이오마커 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제, 동향 분석
제4장 세계의 디지털 바이오마커 시장 : 유형별, 2021-2033년
제5장 세계의 디지털 바이오마커 시장 : 데이터 유형별, 2021-2033년
제6장 세계의 디지털 바이오마커 시장 : 기술 플랫폼별, 2021-2033년
제7장 세계의 디지털 바이오마커 시장 : 최종사용자별, 2021-2033년
제8장 세계의 디지털 바이오마커 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 추천
제11장 참고 문헌과 조사 방법
KSA 26.06.01The global digital biomarker market is estimated to be valued at USD 4,850 Mn in 2026 and is expected to reach USD 16,900 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 19.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4,850 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 19.50% | 2033 Value Projection: | USD 16,900 Mn |
Digital biomarkers are considered to be a revolutionary development in modern healthcare since they provide an opportunity for quantitative analysis of biological data by means of various digital technologies like wearable devices, smartphones, and other types of sensors. As opposed to regular biomarkers, which require frequent visits to clinics and tests, digital biomarkers allow collecting information continuously and passively, thus allowing for a more accurate assessment of patients' health, progress of various diseases, and treatment outcomes. The evolution of digital biomarkers is contributing to the transformation of current healthcare towards data-driven and outcomes-oriented models.
The global digital biomarker industry includes various applications in therapeutic areas that include cardiovascular diseases, neurological disorders, respiratory disorders, mental health conditions, and others. Digital biomarkers can be generated from a variety of data sources, including physiological information, behavioral data, environmental indicators, and other types of information. Technological advancements in sensors, cloud computing, and data aggregation are contributing to the growth and adoption of digital biomarkers.
Market Dynamics
The global digital biomarker market has been driven by increased digitization of healthcare operations and value-driven healthcare delivery and research. More specifically, stakeholders in the healthcare field are looking for a way to gather frequent and objective data on patients to improve their decision-making capabilities and patient treatment outcomes. With the help of digital biomarkers, patients can collect data and use it as quantifiable digital endpoints that will be applied in clinical settings and pharmaceutical research. Additionally, cloud computing systems, as well as mHealth technology and improved data interoperability, increase the scalability and applicability of the aforementioned solutions.
However, the limitations of using digital biomarkers in healthcare include the inability to control the variability of data generated across different devices, insufficiently validated solutions, and difficulties connected to data governance. Nonetheless, multiple opportunities lie in the application of digital twin technology, multi-modal data analysis, and collaboration among different parties from various sectors including healthcare, pharmaceuticals, and technology. The expansion of the application range of digital biomarkers from research to population health management, risk identification, and treatment can further contribute to the growth of the market for digital biomarker.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global digital biomarker market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AliveCor Inc., BioSensics, Evidation Health, Empatica Inc., Koneksa Health, Huma Therapeutics, Altoida AG, IXICO plc, Oura Health, and Verily Life Sciences
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global digital biomarker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital biomarker market
Market Segmentation
- Type Insights (Revenue, USD Mn, 2021 - 2033)
- Diagnostic Biomarkers
- Monitoring Biomarkers
- Predictive and Prognostic Biomarkers
- Data Type Insights (Revenue, USD Mn, 2021 - 2033)
- Physiological Data
- Behavioral Data
- Biochemical / Multi-modal Data
- Technology Platform Insights (Revenue, USD Mn, 2021 - 2033)
- Wearable Devices
- Mobile Applications
- Sensors and Remote Monitoring Devices
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Healthcare Providers
- Research Organizations
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- AliveCor Inc.
- BioSensics
- Evidation Health
- Empatica Inc.
- Koneksa Health
- Huma Therapeutics
- Altoida AG
- IXICO plc
- Oura Health
- Verily Life Sciences
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Digital Biomarker Market, By Type
- Global Digital Biomarker Market, By Data Type
- Global Digital Biomarker Market, By Technology Platform
- Global Digital Biomarker Market, By End User
- Global Digital Biomarker Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Digital Biomarker Market, By Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Diagnostic Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Monitoring Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Predictive and Prognostic Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Digital Biomarker Market, By Data Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Physiological Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Behavioral Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Biochemical / Multi-modal Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Digital Biomarker Market, By Technology Platform, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Wearable Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Mobile Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Sensors and Remote Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Digital Biomarker Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Healthcare Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Digital Biomarker Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- AliveCor Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioSensics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evidation Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Empatica Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Koneksa Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Huma Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Altoida AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IXICO plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oura Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Verily Life Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
